Impact of Diabetes and Glucose Control During Rehabilitation After Stroke

/Home/Complications of Diabetes/Diabetes and Stroke/Clinical Trials for Diabetic Stroke

Impact of Diabetes and Glucose Control During Rehabilitation After Stroke
This study is currently recruiting participants.
Verified by Melbourne Health, October 2005

Sponsors and Collaborators: Melbourne Health
National Health and Medical Research Council, Australia

Information provided by: Melbourne Health
ClinicalTrials.gov Identifier: NCT00241956

Purpose
To assess whether patients with diabetes have less clinical improvement during inpatient rehabilitation than those without diabetes and whether hyperglycaemia during rehabilitation is an adverse prognostic indicator.

Condition
Cerebrovascular Accident
Diabetes
Hyperglycemia

MedlinePlus related topics: Diabetes Rehabilitation

Drug Information available for: Dextrose

U.S. FDA Resources

Study Type: Observational
Study Design: Natural History, Cross-Sectional, Defined Population, Retrospective Study

Official Title: Impact of Diabetes and Glucose Control During Rehabilitation After Stroke


Further study details as provided by Melbourne Health:


Estimated Enrollment: 120
Study Start Date: October 2005

Detailed Description:
Patients with diabetes have a higher mortality rate and more severe disability from stroke compared to those without diabetes. Those with hyperglycaemia tend to progress to a larger final stroke size. Diabetes and hyperglycaemia may affect the ability of the patient to clinically improve, independent of the degree of initial impairment. We will perform a retrospective review of medical records of stroke patients admitted to an inpatient rehabilitation unit. We will compare outcomes of changes in disability scales (FIM and Barthel) from admission to discharge, length of stay and hospital events between those with and without diabetes. Amongst those with diabetes, we will also assess whether those with higher mean blood glucose levels during their inpatient rehabilitation stay have worse outcomes.

Eligibility
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No

Criteria

Inclusion Criteria:

Inpatient rehabilitation for acute stroke
Exclusion Criteria:

Medical records unavailable
Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00241956

Contacts

Contact: Leo Rando, MBBS FRACP +61 3 9342 7365

Contact: Peter G Colman, MD FRACP + 61 9342 7365 peter.colman@mh.org.au

Locations

Australia, Victoria
The Royal Melbourne Hospital Recruiting
Melbourne, Victoria, Australia, 3050


Sponsors and Collaborators

Melbourne Health

National Health and Medical Research Council, Australia

Investigators

Principal Investigator: Leo Rando, MBBS FRACP Melbourne Health

More Information


Study ID Numbers: 2004.246
First Received: October 18, 2005
Last Updated: October 18, 2005
ClinicalTrials.gov Identifier: NCT00241956
Health Authority: Australia: Department of Health and Ageing Therapeutic Goods Administration


Study placed in the following topic categories:
Metabolic Diseases
Cerebral Infarction
Stroke
Vascular Diseases
Diabetes Mellitus
Central Nervous System Diseases
Endocrine System Diseases
Ischemia
Brain Diseases
Cerebrovascular Disorders
Hyperglycemia
Brain Ischemia
Endocrinopathy
Brain Infarction
Metabolic disorder
Infarction
Glucose Metabolism Disorders

Additional relevant MeSH terms:
Nervous System Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on November 13, 2008